RESMED INC — Director's Dealing 2019

Jan 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-01-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-03	ResMed Common Stock	M	4457	$51.25	Acquired	122459	Direct
2019-01-03	ResMed Common Stock	S	4457	$110.82	Disposed	118002	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-03	ResMed Common Stock Options	$51.25	M	4457	Disposed	2020-11-13	ResMed Common Stock (4457)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Represents date options first became exercisable. Options vest 1/3 per year.